ArticleEndocrine connections2022

Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR.

Peter Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.